Molecular Biology of HIV-2
Author:
Lever Andrew M. L.
Publisher
Springer New York
Reference20 articles.
1. Bennett EM, Lever AM, Allen JF. Human immunodeficiency virus type 2 Gag interacts specifically with PRP4, a serine-threonine kinase, and inhibits phosphorylation of splicing factor SF2. J Virol. 2004;78:11303–12.
2. Bolinger C, Boris-Lawrie K. Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome. Retrovirology. 2009;6:8.
3. Boyer PL, Sarafianos SG, Clark PK, Arnold E, Hughes SH. Why do HIV-1 and HIV-2 use different pathways to develop AZT resistance? PLoS Pathog. 2006;2:e10.
4. Briggs JA, Krausslich HG. The molecular architecture of HIV. J Mol Biol. 2011;410:491–500.
5. Camacho RJ. Special aspects of the treatment of HIV-2-infected patients. Intervirology. 2012;55:179–83.